The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The influence of patient-reported adverse events on Health Utility Score (HUS) and Health-Related Quality of Life (HRQoL) in small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) patients.
 
Sharara Shakik
No Relationships to Disclose
 
Ali Vedadi
No Relationships to Disclose
 
M. Catherine Brown
No Relationships to Disclose
 
Wei Xu
No Relationships to Disclose
 
Grainne M. O'Kane
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - AstraZeneca; AstraZeneca/MedImmune; Merck Serono; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche Canada; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Novartis; Takeda
Speakers' Bureau - AstraZeneca
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Natasha B. Leighl
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
 
Penelope Ann Bradbury
Honoraria - Abbvie; Merck; Pfizer
 
Benjamin H. Lok
No Relationships to Disclose
 
Adrian G. Sacher
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Gritstone Bio; Pfizer